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ABSTRACT: Secondary active-site residues in enzymes, including hydrophobic amino acids, may contribute
to catalysis through critical interactions that position the reacting molecule, organize hydrogen-bonding
residues, and define the electrostatic environment of the active site. To ascertain the tolerance of an important
model enzyme to mutation of active-site residues that do not directly hydrogen bond with the reacting
molecule, all 19 possible amino acid substitutions were investigated in six positions of the engineered
chorismate mutase domain of the Escherichia coli chorismate mutase-prephenate dehydratase. The six
secondary active-site residues were selected to clarify results of a previous test of computational enzyme
design procedures. Five of the positions encode hydrophobic side chains in the wild-type enzyme, and
one forms a helix N-capping interaction as well as a salt bridge with a catalytically essential residue.
Each mutant was evaluated for its ability to complement an auxotrophic chorismate mutase deletion strain.
Kinetic parameters and thermal stabilities were measured for variants with in ViVo activity. Altogether,
we find that the enzyme tolerated 34% of the 114 possible substitutions, with a few mutations leading to
increases in the catalytic efficiency of the enzyme. The results show the importance of secondary amino
acid residues in determining enzymatic activity, and they point to strengths and weaknesses in current
computational enzyme design procedures.
Chorismate mutases catalyze the Claisen rearrangement
of chorismate to prephenate (Scheme 1). This reaction is an
essential step in the biosynthesis of aromatic compounds
including tyrosine and phenylalanine in plants, bacteria, and
fungi. Isotope studies have established that both solution and
enzyme-catalyzed rearrangements proceed through a chairlike
transition state (1, 2) in a concerted, asynchronous [3,3]-
sigmatropic process (3-5).
As an intramolecular reaction that appears to be catalyzed
without intermediate steps, covalent catalysis, or modification
of the reaction pathway, the chorismate-prephenate rear-
rangement has become an important model system for
theoretical approaches to the study of enzyme catalysis
(recently reviewed in ref 6). These same features make the
reaction a compelling model for evaluating procedures for
computational enzyme design. In earlier work (7), we tested
computational enzyme design methods (8) through redesign
of the active site of a chorismate mutase. Amino acid
identities and conformations were optimized for 18 active-
site residues in the presence of an ab initio calculated
transition state structure. The calculation returned wild-type
residues in 12 of 18 designed positions, and the six mutations
predicted by the calculation were to amino acids that do not
make hydrogen bond contacts to the reacting molecule.
Because the active-site environment is likely to present
significant challenges to protein design energy functions that
are typically tuned for global stability (9, 10), we sought to
better define the consequences for both stability and catalysis
of mutating these six secondary active-site positions of the
natural enzyme.
Two structurally distinct chorismate mutase forms have
been identified. While the Bacillus subtilis enzyme (BsCM)1
and other AroH mutases adopt a homotrimeric pseudo-R/â-
barrel fold (11), the AroQ mutases from Escherichia coli
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and other organisms are all-helical proteins (12-15). Cho-
rismate mutases from E. coli are fused to their downstream
biosynthetic partners, yielding bifunctional chorismate mu-
tase-prephenate dehydratase (P-protein) and chorismate
mutase-prephenate dehydrogenase (T-protein) enzymes (16).
Mechanistic investigations of the bifunctional T-protein
enzyme were complicated by a rate-limiting step other than
the Claisen rearrangement (3). However, truncated, mono-
functional constructs of the P-protein (Figure 1A, referred
to as EcCM herein) have permitted structural and mechanistic
studies of an isolated AroQ chorismate domain (17). The
rearrangement catalyzed by EcCM shows expected patterns
of kinetic isotope effects and no sensitivity to viscosogens,
strongly suggesting that the Claisen rearrangement is the rate-
determining step (5, 18). In contrast, BsCM appears to be
limited partially by a diffusive process and partially by the
chemical step (4, 18).
Previous mutagenesis and selection studies of both EcCM
and BsCM enzymes have demonstrated that efficient catalysis
depends on positively charged active-site residues poised to
interact with substrate carboxylates and ether oxygen as well
as negatively charged side chains able to contact the substrate
hydroxyl group (19-25).
The present work focuses on secondary active-site side
chains that do not hydrogen bond with the reacting molecule
but nonetheless may participate in catalysis by positioning
the substrate, organizing charged and polar active-site
residues, or defining the electrostatic environment of the
active site (26-31). The impact of secondary active-site
residues on catalytic activity is an important concern for de
noVo computational enzyme design efforts, because common
methods strongly emphasize placement of primary catalytic
residues (8, 32-35). Secondary active-site residues may also
have special consequences for enzyme stability. Prior mu-
tagenesis studies have found inverse relationships between
changes in protein stability and changes in activity following
the mutation of active-site residues, consistent with a notion
that creation of a cavity with specialized electrostatic
properties opposes the normal driving forces of protein
stability (36-40).
We have evaluated the effects of all 19 possible single
mutations to the six EcCM active-site residues that were
mutated in our previous computational design experiment:
Leu7, Ala32, Val35, Asp48, Ile81, and Val85 (Figure 1B).
Each of the 114 variants was tested for complementation of
the chorismate mutase deficiency of the auxotrophic E. coli
KA12/pKIMP-UAUC system of Kast, Hilvert, and co-
workers (22). Biologically active variants were purified, and
their in Vitro thermal stabilities and steady-state kinetic
parameters were assessed.
MATERIALS AND METHODS
Materials and Strains. E. coli KA12 and plasmid pKIMP-
UAUC have been described previously (22, 41). Chorismic
acid (97.5%) was purchased from Sigma-Aldrich.
Construction and in ViVo EValuation of Mutants. The
chorismate mutase domain (consisting of the 109 N-terminal
residues of the P-protein) described by Ganem and co-
workers (17) was previously fused to the C-terminus of a
self-cleavable chitin binding domain-intein fusion construct
(IMPACT-CN, New England Biolabs) (7). The QuikChange
multisite mutagenesis kit (Stratagene) was used to create site-
specific variants in this construct by using single oligonucle-
otides bearing degenerate codons (i.e., NNK) in the position
of interest. After transformation of XL10-gold cells (Strat-
agene), DNA was prepared directly from plated colonies and
subsequently used to transform KA12/pKIMP-UAUC. Cells
were plated on both selective media and nonselective media.
M9c minimal agar plates were prepared as described (42)
except that 20 íg/mL L-phenylalanine was included in the
selective plates (nonselective plates contained both L-
phenylalanine and L-tyrosine). To facilitate identification of
active variants, mutagenesis reactions were performed with
inactive templates (i.e., stop codons in the position of
interest), and DNA was sequenced from viable colonies on
selective media. Inactive variants were identified by perform-
ing the mutagenesis reaction on a wild-type template and
looking for colonies that were nonviable when streaked onto
selective media plates. To recover missing variants, mu-
tagenesis reactions with nondegenerate and less-degenerate
oligonucleotides were performed. Biological activity or
inactivity was confirmed by retransformation of isolated
plasmid DNA and plating on selective and nonselective
media. All reported constructs were verified by DNA
sequencing over the entire EcCM coding region.
1 Abbreviations: EcCM, chorismate mutase domain of E. coli
chorismate mutase-prephenate dehydratase (P-protein); BsCM, Bacillus
subtilis chorismate mutase; CD, circular dichroism.
FIGURE 1: Truncated, monofunctional chorismate mutase domain
from E. coli chorismate mutase-prephenate dehydratase in complex
with a transition state analog (dark gray carbons), from pdb code
1ecm: (A) overall fold, showing the two chains of the symmetric
homodimer in teal and gold with the bound transition state analog
shown as a CPK model; (B) active-site residues investigated in
this study shown with light gray carbon atoms.
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Because the N-terminal gene fusion was not sequenced
for each variant, we investigated the possibility that disrup-
tion of activity might be caused by deleterious mutations to
the promoter region or the N-terminally fused chitin-binding/
intein region rather than by mutation of the enzyme itself.
Evidence against such artifacts was provided for some
inactive variants by multiple independent occurrences of the
same mutation with identical behavior. For the remaining
inactive variants, small-scale expression tests followed by
SDS-PAGE verified the presence of appropriately sized,
overproduced protein. Any frameshift within the N-terminal
fusion protein would encounter multiple stop codons leading
to a visibly truncated protein. Similar expression tests of the
N-terminal fusion protein alone showed that the size differ-
ence was readily apparent.
In position 48, some variants displayed ambiguous be-
havior, with only a few colonies growing on selective media.
For position 48 variants, an arbitrary threshold was applied,
such that a variant was considered biologically active if at
least 10% of the number of colonies were observed on
selective media as on nonselective media when equal
amounts were plated. This resulted in a stringent test for
activity, where active variants exhibited at least 5% of wild-
type kcat/Km.
Protein OVerproduction and Purification. Biologically
active constructs were expressed in E. coli BL21 DE3.
Overexpression was induced with 1 mM IPTG followed by
growth at room temperature. Cells were lysed using an
Emulsiflex-C5 (Avestin), and the fusion proteins were
affinity purified with chitin agarose (New England Biolabs).
Affinity tag self-cleavage was induced with 50 mM DTT at
25 °C. Mass spectrometry and SDS-PAGE previously
indicated that this procedure results in the desired EcCM
construct (7). Proteins were further purified by gel filtration
in 50 mM Tris-HCl, pH 7.8, 100 mM NaCl. A well-resolved
dimer peak was collected, and variants with significant
higher-order aggregation were not further considered. We
expected that affinity purification followed by gel filtration
would eliminate any significant catalytic contribution of
endogenous E. coli CM enzymes, since they do not have
the affinity tag and are considerably larger in size. In fact,
no activity was detected when concentrated extracts from
cells harboring empty pTYB-11 fusion vector were subjected
to identical purification steps and assay procedures. For
consistency with previously published kinetic studies of the
same construct (7, 23, 43), protein concentration was
determined by the Bradford assay using BSA as a standard
(Bio-Rad).
CD Spectrometry and Thermal Denaturation. Far-UV
circular dichroism (CD) spectra were collected at the activity
assay temperature of 37 °C. All variants showed nearly
superimposable wavelength scans. Thermostability was as-
sessed by thermal denaturation monitored by CD at 222 nm.
CD was monitored using an Aviv 62DS spectrometer and a
1 mm path length cell. Increments of 1 °C were used with
an equilibration time of 90 s and a signal averaging time of
30 s. Buffer conditions were 50 mM Tris-HCl, pH 7.8,
100 mM NaCl. Midpoints of thermal denaturation (Tm) were
obtained by fitting the data to a two-state model (44). It
should be noted, however, that unfolding was not reversible
and some samples showed clear evidence of non-two-state
behavior, so Tm values should be taken as estimates of
relative stabilities rather than thermodynamic parameters. CD
data were collected at 22 ( 3 íM protein. Variations in Tm
from different concentrations within the range were similar
to variations across multiple trials.
Kinetic Assays. Activities were measured by following the
absorbance of chorismate at 275 nm ( ) 2630 M-1 cm-1
(3)). Activity assays were performed at 37 °C in 50 mM
Tris-HCl, pH 7.8, 2.5 mM EDTA, 20 mM â-mercaptoetha-
nol, and 0.01% BSA, conditions used in prior studies of the
same construct (7, 23, 43). Given pKa’s for chorismate and
prephenate of <4.5 (45), these conditions ensure that the
reaction of chorismate2- to prephenate2- was monitored. A
protein concentration of 20 nM was generally used; however,
less-active variants were assayed with 40 or 100 nM protein.
For cases where kcat and Km are reported, at least three trials
with nine or more data points each were performed, and
substrate concentration ranges of at least 0.3-3 times Km
were used. Kinetic parameters were determined by nonlinear
fitting of the buffer-corrected initial rates to the Michaelis-
Menten equation.
RESULTS
The effects of all possible single amino acid substitutions
were evaluated in six positions in the chorismate mutase
domain of the E. coli P-protein (Table 1). Each construct
was evaluated for its ability to complement the KA12/
pKIMP-UAUC system (22, 41), which requires chorismate
mutase activity for viability in media lacking tyrosine and
phenylalanine. Of the 114 mutants, 39 (or 34%) were scored
as active.
EcCM variants promoting viability were purified, and their
in Vitro stabilities and kinetic parameters were evaluated.
Of the mutants active in ViVo, measured Tm values ranged
approximately (10 °C relative to wild type, yet the average
Tm (61.6 °C) was remarkably similar to that of the wild type
(61.4 °C). In Vitro enzyme activities were reduced relative
to wild type, except in a few cases. The greatest increase in
activity relative to wild type was found with the Ala32Ser
mutation, previously reported as the result of a computational
design approach (7). This mutation results in an ap-
proximately 60% increase in catalytic efficiency with less
than 1 °C change in Tm.
Position 7. Based on the wild-type structure with bound
transition state analog (1ecm), Leu7 lies near the carboxylate
of the enolpyruvyl moiety, and the catalytically essential
residue Arg11 is sandwiched between Leu7 and Arg51 from
the adjacent helix. Six relatively conservative side chain
substitutions were tolerated in this position. Substitution of
phenylalanine or isoleucine for wild-type leucine maintained
catalytic efficiency within 10%, and the leucine to isoleucine
mutation increased Tm by 4.4 °C.
Position 32. Ala32 lies closest to the forming C-C bond
and the cyclohexadienyl face carboxylate, based on the 1ecm
structure. Although six alternative side chains were tolerated
in position 32, only the Ala32Ser and Ala32Thr variants
could be readily purified without precipitation or aggregation.
The Ala32Ser and Ala32Thr mutations increased catalytic
efficiency by 62% and 23%, respectively.
Position 35. Val35 is expected to pack against the
enolpyruvyl moiety of the reacting molecule. In addition,
this residue closely neighbors the catalytically important
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Table 1: Results for Complementation Tests, Kinetic Parameters, and Thermal Stabilitiesa
pos 7 C/NCb kcat, s-1 Km, íM
kcat/Km,
M-1 s-1 Tm, °C pos 48 C/NCb kcat, s-1 Km, íM
kcat/Km,
M-1 s-1 Tm, °C
Ala - Ala -
Arg - Arg -
Asn - Asn + >750 7.9  103 56.5
Asp - Asp* + 39 ( 5 300 ( 50 1.3  105 61.4 ( 0.6
Cys + >750 1.0  104 52.0 Cys + >750 1.8  104 53.8
Gln - Gln + >750 9.8  103 55.5
Glu - Glu -
Gly - Gly -
His - His -
Ile + 36 ( 2 300 ( 80 1.2  105 65.8 Ile -
Leu* + 39 ( 5 300 ( 50 1.3  105 61.4 ( 0.6 Leu + >750 7.1  103 57.7
Lys - Lys -
Met + >750 4.4  104 60.3 Met -
Phe + 48 ( 2 350 ( 30 1.4  105 62.3 Phe -
Pro - Pro -
Ser - Ser -
Thr + >750 1.3  104 59.2 Thr -
Trp - Trp -
Tyr - Tyr -
Val + 36 ( 3 700 ( 100 5  104 61.9 Val -
pos 32 C/NCb kcat, s-1 Km, íM
kcat/Km,
M-1 s-1 Tm, °C pos 81 C/NCb kcat, s-1 Km, íM
kcat/Km,
M-1 s-1 Tm, °C
Ala* + 39 ( 5 300 ( 50 1.3  105 61.4 ( 0.6 Ala -
Arg - Arg -
Asn - Asn -
Asp - Asp -
Cys + aggr Cys + aggr
Gln - Gln -
Glu - Glu -
Gly + aggr Gly -
His - His -
Ile + aggr Ile* + 39 ( 5 300 ( 50 1.3  105 61.4 ( 0.6
Leu - Leu + >750 5.5  104 57.7
Lys - Lys -
Met - Met + 27 ( 2 270 ( 20 1.0  105 64.6
Phe - Phe + >750 8.7  103 59.0
Pro - Pro -
Ser + 45 ( 6 220 ( 30 2.1  105 61.7 Ser -
Thr + 61 ( 4 380 ( 70 1.6  105 62.8 Thr -
Trp - Trp + aggr
Tyr - Tyr -
Val + aggr Val + aggr
pos 35 C/NCb kcat, s-1 Km, íM
kcat/Km,
M-1 s-1 Tm, °C pos 85 C/NCb kcat, s-1 Km, íM
kcat/Km,
M-1 s-1 Tm, °C
Ala + 20 ( 2 520 ( 90 3.9  104 61.2 Ala + >750 1.2  104 62.7
Arg - Arg + >750 4.2  104 66.9
Asn - Asn + >750 1.2  104 66.8
Asp - Asp -
Cys + 18.6 ( 0.6 360 ( 40 5.2  104 61.8 Cys + 32 ( 4 570 ( 90 5.4  104 54.7
Gln - Gln -
Glu - Glu -
Gly - Gly -
His - His -
Ile + 65 ( 9 440 ( 80 1.5  105 66.6 Ile + 55 ( 1 550 ( 30 1.0  105 62.9
Leu + >750 1.3  104 66.7 Leu + >750 4.3  104 62.2
Lys - Lys + >750 1.3  104 67.1
Met + >750 5.2  104 68.9 Met + >750 1.5  104 65.6
Phe - Phe + >750 2.1  104 61.7
Pro - Pro -
Ser - Ser -
Thr + >750 2.0  104 56.5 Thr + >750 2.2  104 62.1
Trp - Trp + aggr
Tyr - Tyr + >750 2.6  104 65.7
Val* + 39 ( 5 300 ( 50 1.3  105 61.4 ( 0.6 Val* + 39 ( 5 300 ( 50 1.3  105 61.4 ( 0.6
a Assays were performed at 37 °C and pH 7.8; see Materials and Methods. Wild-type residues are indicated with bold type and asterisks, and
wild-type values differ by less than 5% from published values for the same construct and conditions (23, 43). aggr indicates that protein precipitated
or aggregated during purificiation. Where uncertainties are indicated, the means and standard deviations from at least three trials are reported.
b Variants complementing the deletion strain are indicated by +, noncomplementing by -.
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residues Lys39 and Gln88, both of which contact the ether
oxygen of the breaking bond. Six substitutions were tolerated
in this position, with four leading to increased thermostability.
The Val35Met, Val35Leu, and Val35Ile mutations increased
Tm by 7.5, 5.3, and 5.2 °C, respectively. All mutations led
to increased Km, and all led to between 2- and 10-fold
decreases in catalytic efficiency except for Val35Ile, which
showed a 15% increase.
Position 48. In the wild-type structure, Asp48 hydrogen
bonds with both the N-terminus of the second helix in EcCM
and Arg11, a critical residue that contacts the transition state
analog in the crystal structure (Figure 2). Four position 48
mutants were scored as biologically active, and all four
showed reductions in Tm of 3-8 °C and large increases in
Km.
Position 81. Ile81 is expected to pack closely against the
cyclohexadienyl face carboxylate of the reacting molecule.
Six substitutions of this residue were tolerated, although the
cysteine, tryptophan, and valine mutants were prone to
aggregation in Vitro. Aside from a 3.2 °C increase in stability
with the Ile81Met mutation, the substitutions for which data
could be obtained led to reduced stability and catalytic
efficiency.
Position 85. Val85 lies adjacent to Ile81 and close to the
cyclohexadienyl face of the reacting molecule at the breaking
bond carbon, based on the 1ecm structure. Its CR-Câ vector
is directed more toward solvent than that of Ile81, however.
Position 85 was broadly tolerant of substitution, allowing
12 of 19 possible mutations. Interestingly, 9 of the 11 mutants
for which data were recorded resulted in increased Tm relative
to wild-type, while all of the mutants yielded significant
increases in Km.
DISCUSSION
Tolerance to Mutation. In this study, 34% of all single
mutants were scored as biologically active. While it is
difficult to compare results across systems because of
variations in cellular requirements, expression levels, initial
protein stability (46-48), and various other factors, this value
is consistent with other mutational studies. A sampling from
among the many exhaustive and random mutagenesis studies
suggests that between 50% and 85% of single mutations
typically maintain some level of function, while in catalytic
sites, 20-60% on average preserve some function (49-57).
Thus, the amino acid positions studied here have tolerances
to single mutation that are similar to active-site residues in
other enzymes.
Helix N-Capping Position. The N-termini of R helices are
preceded by residues with distinct preferences for side chains
that can satisfy unpaired helical hydrogen bond donors. These
N-capping residues are reflected in protein database surveys,
protein stability measurements, and model peptide studies
(reviewed in ref 58). N-cap residues can affect helix stability
by as much as 4 kcal/mol (59) and are found to be important
considerations in protein design (60). The 1ecm crystal
structure suggests that Asp48 occupies an ideal geometry
for simultaneous N-capping and salt bridge formation with
Arg11, a critical residue that contacts the transition state
analog (Figure 2). Mutational studies have shown the
importance of Arg11 to catalysis; the Arg11Lys and Arg11Ala
mutations lead to 103-fold and 104-fold reduction in catalytic
efficiency, respectively (20).
The reduction in stability of all biologically active position
48 variants coincides with previous studies placing aspartic
acid as one of the most favored N-capping residues (61-
63). The loss in activity upon mutation may suggest that the
Asp48-Arg11 salt bridge is important for positioning of the
catalytically important arginine. Alternatively, the interaction
may have a role in the substrate binding process. The salt
bridge spans the interface between two helices proposed to
offer the site of entry into the binding pocket. Structural
studies on related enzymes suggest that these two helices
move relative to each other, potentially opening an entry
pathway (14). Mutations in position 48 could conceivably
interfere with the substrate entry process, which may be
reflected in the increased Km values. The fact that Asp48Asn
and Asp48Gln mutants were scored as active while Asp48Glu
was not could suggest that a very precise geometric position-
ing is required for the catalytic process, which may be
compromised in a backbone-Glu48-Arg11 hydrogen bond
network.
Comparison to Other AroQ Family Members. Table 2
shows the structural equivalents of each of the six residues
in crystal structures of AroQ chorismate mutases from four
other organisms. For each structure, sequence variations
among closely related homologs were determined by BLAST
searches of the RefSeq database (64, 65). A number of the
sequence variations seen in the homologs were found to
retain wild-type-like or have increased activity in the EcCM
scaffold: Leu7Ile, Ala32Ser, Ala32Thr, and Val35Ile. Four
other mutations were also observed in the sequence align-
ments but led to precipitated or aggregated protein in Vitro:
Ala32Val, Ala32Gly, Ala32Cys, and Ile81Val. The majority
of the alternative residues found in the sequence alignments,
however, led in EcCM to reduced in Vitro activity or loss of
function in the in ViVo assay. Clearly, sequence alignments
provide information about possible substitution tolerances
in a given enzyme scaffold, but activity is ultimately
determined within the structural context of the specific
protein.
The considerable tolerance to mutation seen with position
85 is also reflected in the sequence alignments. Related
FIGURE 2: Interactions of Asp48 with the N-terminus of the second
helix and with Arg11. The carbon atoms of the bound transition
state analog are in gray, while those of the side chains are colored
in teal and gold to indicate their association with the corresponding
EcCM chain. Many side chains, protons, and other elements are
omitted for clarity.
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proteins feature alternatives including glutamic acid, lysine,
and arginine, consistent with the higher solvent exposure of
this position. While a previous selection study reported the
equivalent of position 85 in Methanococcus jannaschii CM
to be highly conserved (66), that observation may reflect
interactions not present in the EcCM structure. The equiva-
lent position is occupied by lysine in the M. jannaschii
enzyme, as well as in the Saccharomyces cereVisiae and
Pyrococcus furiosus enzymes, where crystal structures show
the lysine engaging in salt bridge interactions with a
neighboring helix (13). Curiously, the equivalent of position
85 in the Mycobacterium tuberculosis enzyme makes a
catalytically important contact to the hydroxyl group of the
transition state analog that replaces the interaction made in
EcCM by Glu52 (14), again suggesting that the role of this
position may be strongly scaffold-dependent.
In position 48, the sequence alignments showed much
more variation in amino acid identity than was experimen-
tally found to be compatible with EcCM function. Changes
in helix register in some of the homologs may be partially
responsible for these large variations.
Tradeoff between Stability and ActiVity. Various authors
have considered the view that evolutionary optimization of
active-site residues for binding of transition states would lead
to selection of residues that are not optimal for protein
stability (36-40). Implicit in the argument is the idea that
stabilizing interactions that the enzyme devotes to the
reacting molecule are both unsatisfied and likely destabilizing
to the protein when the molecule is not bound. A laboratory-
evolved chorismate mutase dramatically illustrated this
principle by transforming from an apparent molten globule
into a more ordered protein in the presence of a transition
state analog (67, 68).
Although a correlation was not seen between changes in
stability and activity of the chorismate mutase variants
studied here (see Supporting Information), some of the
mutants are consistent with the notion of a stability-activity
tradeoff. More mutants (20) showed increased stability than
decreased stability (12). In position 85 of EcCM, all of the
11 biologically active mutants for which data could be
obtained showed reduced catalytic efficiency and an in-
creased Km value and nearly all mutants exhibited increased
thermostability. Because Val85 participates in van der Waals
interactions with both the transition state analog and residues
from neighboring helices in the 1ecm structure, chorismate
binding and stability could be affected by altering the shape
of the binding pocket or by interfering with helix-helix
interactions that contribute to the structural fortitude of the
active site. Specifically, movement of the neighboring helix
has been proposed to facilitate substrate entry (14) and
modified helix-helix interaction could thus affect substrate
affinity. Also, in position 35, all biologically active mutations
increased the Km. While not all of the mutations led to
increased Tm values, three showed increases in thermosta-
bility of more than 4 °C. Val35 in the 1ecm structure appears
to participate in van der Waals interactions with the transition
state analog, the catalytically important residues Lys39 and
Gln88, and some neighboring helix residues. While the
present study cannot be expected to determine the relative
contributions of these interactions to EcCM function, it
clearly suggests that this residue contributes to the catalytic
process and the global stability of the protein.
Relationship to Models of EcCM Catalytic Mechanism.
Among theorists, differing computational treatments of
chorismate mutase systems have led to varied descriptions
of the origin of enzymatic catalysis of the reaction. Despite
an observation that the chemical step is not fully rate-limiting
in the BsCM enzyme (18), the majority of work has modeled
that active site (69-87). The few computational investiga-
tions of EcCM have proposed, in opposition to most of the
other studies, that both enzymes accelerate the rearrangement
exclusively by restricting the conformational space of the
substrate and not by stabilizing the transition state (78, 88-
90). These studies, and an earlier one (91), explicitly
identified Val35 and Ile81 as mediators of substrate confor-
mational restriction. Although we find that both positions
tolerate a number of mutations, we do not expect the data
provided here to allow for differentiation between possible
modes of EcCM catalysis.
For example, the Val35Ile mutation leads to an increase
in kcat and the Val35Ala mutation leads to a decreased kcat
value. While these mutations would be expected to reduce
and increase the conformational freedom of the bound
substrate, respectively, the changes in kcat are relatively
modest and could be attributed to any number of factors. In
addition to its close proximity to the reacting molecule, Val35
is within van der Waals contact distance of the catalytically
essential Lys39 and a number of other residues. Perturbations
to any of these interactions could have consequences for the
geometry and energetics of critical hydrogen bonds, leading
to changes in relative stabilization of the transition state.
Simple continuum electrostatics calculations suggest that
these mutations could also lead to small changes in electro-
static potential at the reacting molecule. In short, hydrophobic
active-site residues perform important functions in active
sites, but it is difficult to isolate their precise effects on
catalysis.
Implications for Enzyme Design. In the computational
design experiment previously performed by our group (7),
the global minimum energy sequence for 18 designed EcCM
active-site residues contained mutations to only the six
positions of the present study: Leu7Ile, Ala32Ser, Val35Ile,
Asp48Ile, Ile81Leu, and Val85Ile. Of these six mutations,
two were found to be the most active of all possible single
Table 2: Structural Alignment of Solved AroQ Mutase Structures and BLAST Resultsa
E. coli; 1ecm Leu7 Ala32 [STV] Val35 [I] Asp48 [AEKQSTV] Ile81 [L] Val85
S. cereVisiae; 4csm Leu12 Gly161 Val164 Asn194 [DYFKS] Ile239 [M] Lys243
M. tuberculosis; 2fp2 Leu130 Ala53 Val56 [IM] Asp69 Ile102 Glu106 [KV]
P. furiosus; 1ybz Leu4 Ala29 [CS] Ile32 [M] Asp45 [V] Leu67 [V] Lys71 [R]
T. thermophilus; 2d8d Ile5 [LM] Val30 [A] Ile33 [V] Asp46 Phe78 Leu82 [T]
a Structures from the pdb codes indicated were aligned over the transition state analog if present and otherwise over all residues. For each pdb
protein sequence, protein-protein BLAST (64) was performed using the RefSeq database (65). Variations of the position are reported in brackets
for matches with bitscores of 85 or greater (60 for 1ybz); these scores corresponded to sequences with 40% sequence identity or greater.
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substitutions for the given amino acid position, and one was
found to be the most stable variant of the amino acid position.
While the five hydrophobic positions were generally
modeled well, the strong preference for aspartate in position
48 is not well represented by the molecular mechanics and
rotamer library-based protein design approach. In typical
energy models used for design, repulsion of the charged
aspartate side chain with the carboxylate of the reacting
molecule results in disfavoring of the wild-type position 48
residue. Regardless of whether Asp48 contributes to catalysis
by positioning of the critical Arg11, solidifying the local
structure around the helix N-terminus, or contributing to
substrate entry into the binding site, the effect of this residue
is likely due to complex and cooperative effects of Asp48
that are difficult to model in a design calculation. Present
computational protein design models typically neglect ex-
plicit treatment of side-chain entropy, electron polarization,
the unbound state of the protein, and changes in backbone
structure, any of which could prove critical in defining the
energetics that underlie the strong requirement for aspartate
in position 48. The present dataset will enable a more detailed
evaluation of the strengths and weaknesses of various energy
functions for design.
Finally, the ability of EcCM to tolerate a number of
mutations without reduction in stability or activity is in
accord with previous descriptions of active-site plasticity.
Secondary active-site positions that accept side chain sub-
stitutions can allow evolution or design of enzymes with new
substrate specificities and chemical mechanisms, sometimes
without disruption of the original function (92-95). These
secondary positions offer rich opportunities for testing and
refining enzyme design methodologies through active-site
redesign experiments.
SUPPORTING INFORMATION AVAILABLE
A plot showing changes in activity with changes in
stability for the mutants. This material is available free of
charge via the Internet at http://pubs.acs.org.
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